Adrenal corticosteroid inhibitors are drugs that inhibit key steps in the biosynthesis of hormones produced by the adrenal cortex, such as mineralocorticoids, glucocorticoids, estrogen and androgen. Adrenal corticosteroid inhibitors block one or more enzymes in the steroid synthesis pathway. They are used to treat Cushing’s syndrome and some types of cancers. They are also used as diagnostic tools, such as in procedures to check pituitary function ⁴.
Introduction:
Adrenal corticosteroid inhibitors are a class of drugs that are used to treat various medical conditions. They work by blocking the production of hormones in the adrenal cortex ⁴.
Meta Description: Adrenal corticosteroid inhibitors are drugs that inhibit key steps in the biosynthesis of hormones produced by the adrenal cortex. They are used to treat Cushing’s syndrome, breast cancer, and prostate cancer. Research is ongoing to develop new and more effective adrenal corticosteroid inhibitors that have fewer side effects .
Segments:
Adrenal corticosteroid inhibitors are classified based on the type of enzyme they inhibit in the steroid synthesis pathway. Some of the commonly used adrenal corticosteroid inhibitors include:
1. Metyrapone: This drug inhibits the enzyme 11-beta-hydroxylase, which is involved in the production of cortisol ⁴.
2. Aminoglutethimide: This drug inhibits the enzyme cytochrome P450scc, which is involved in the production of all steroid hormones ⁴.
3. Ketoconazole: This drug inhibits the enzyme cytochrome P450c17, which is involved in the production of androgens and estrogens ⁴.
Benefits:
Adrenal corticosteroid inhibitors are used to treat a variety of medical conditions, including Cushing’s syndrome, breast cancer, and prostate cancer ⁴. They are also used as diagnostic tools to check pituitary function ⁴.
Developments:
Research is ongoing to develop new adrenal corticosteroid inhibitors that are more effective and have fewer side effects. Some of the areas of research include:
1. Developing inhibitors that target specific enzymes in the steroid synthesis pathway .
2. Developing inhibitors that are more selective and have fewer side effects .
The adrenal corticosteroid inhibitors market is expected to grow at a CAGR of around 12.5% from 2023 to 2030, according to a report by Data Bridge Market Research. The market was valued at USD 2.25 billion in 2022 and is expected to reach USD 5.77 billion by 2030. The rise in incidence of prostate cancer is boosting the adrenal corticosteroid inhibitor drugs market. In 2012, above 1.1 million cases of prostate cancer were witnessed, accounting for around 15% of cases in men and nearly 8% of total new cases. The market report also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
According to the report by Data Bridge Market Research, the major countries covered in the adrenal corticosteroid inhibitors market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina, and Rest of South America as part of South America ¹. North America has been witnessing a positive growth for adrenal corticosteroid inhibitors market throughout the forecasted period due to the high demand of diseases specific treatment and increased patient awareness level as well as high prevalence of breast cancer and Cushing’s disease ¹.
Conclusion:
Adrenal corticosteroid inhibitors are an important class of drugs that are used to treat various medical conditions. They work by blocking the production of hormones in the adrenal cortex. While they are effective in treating many conditions, they can also have side effects. Research is ongoing to develop new and more effective adrenal corticosteroid inhibitors that have fewer side effects .
Get more Info:https://www.databridgemarketresearch.com/reports/global-adrenal-corticosteroid-inhibitors-market